Drugs Made In America Acquisition II Corp.
DMII
$9.92
$0.050.51%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 09/30/2024 | ||
|---|---|---|---|---|---|
| Net Income | -46.20K | -38.10K | -59.30K | -- | |
| Total Depreciation and Amortization | -- | -- | -- | -- | |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | |
| Total Other Non-Cash Items | -78.70K | 47.20K | -- | -- | |
| Change in Net Operating Assets | -565.80K | -11.70K | 49.30K | -- | |
| Cash from Operations | -690.70K | -2.60K | -10.00K | -- | |
| Capital Expenditure | -- | -- | -- | -- | |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | |
| Divestitures | -- | -- | -- | -- | |
| Other Investing Activities | -500.00M | -- | -- | -- | |
| Cash from Investing | -500.00M | -- | -- | -- | |
| Total Debt Issued | -- | -- | -- | -- | |
| Total Debt Repaid | -533.80K | -- | -- | -- | |
| Issuance of Common Stock | 502.00M | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | |
| Issuance of Preferred Stock | -- | -- | -- | -- | |
| Repurchase of Preferred Stock | -- | -- | -- | -- | |
| Total Dividends Paid | -- | -- | -- | -- | |
| Other Financing Activities | -464.80K | -- | -- | -- | |
| Cash from Financing | 501.00M | -- | -- | -- | |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | |
| Net Change in Cash | 310.70K | -2.60K | -10.00K | -- | |